Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 259.30
+2.50 (0.97%)
At close: Apr 16, 2026
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 27.17 billion as of April 16, 2026. Its market cap has increased by 109.95% in one year.
Market Cap
27.17B
Enterprise Value
26.04B
Revenue
8.68B
Ranking
n/a
PE Ratio
25.20
Stock Price
259.30
Market Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 27.17B, an increase of 270,162.36%. That is a compound annual growth rate of 38.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 27.17B | 57.06% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 57.96B |
| Gufic Biosciences | 30.82B |
| Novartis India | 24.51B |
| Unichem Laboratories | 24.42B |
| Hikal | 23.25B |
| Morepen Laboratories | 22.61B |
| Kwality Pharmaceuticals | 16.06B |
| Amrutanjan Health Care | 15.57B |